Approval · Notice of Compliance 35570 · 2025
IMJUDO: Notice of Compliance 35570
Issued June 20, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35570
- Date
- June 20, 2025
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMJUDO | Not yet assigned | — |
Medicinal ingredients
- TREMELIMUMAB 20 MG per ML
- TREMELIMUMAB 300 MG per ML